SCHEMBL2310488

SCHEMBL2310488

O=c1c2ccccc2sc2c(CCO)c(CCO)ccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
ALDH1A1 P00352 4/20 0.43
LMNA P02545 3/20 0.43
POLB P06746 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HCRTR1 O43613 2/20 0.43
CYP19A1 P11511 1/20 0.41
RAB9A P51151 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
HIF1A Q16665 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ABCB11 O95342 1/20 0.40
TP53 P04637 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2310829 0.84 CYP19A1 (0.53) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL2308120 0.80 MAOA (0.48) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL2309510 0.79 MAPT (0.49) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL30298294 0.78 MAPT (0.46) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL9660660 0.78 MAPT (0.46) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL2308573 0.76 MAPT (0.48) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL3484127 0.75 MAPT (0.53) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL2311180 0.75 KDM4E (0.51) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL2313006 0.72 CYP19A1 (0.40) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL2309971 0.72 KDM4E (0.47) MAPTALDH1A1LMNAPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed